Dr. Alicia Ann Mirza, MD

Dr. Mirza practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Mirza's NPI, 1922443696, was assigned on May 7, 2013. Dr. Mirza graduated from Loyola University Chicago Stritch School of Medicine in 2013. Dr. Mirza holds California license A135317.

Dr. Mirza's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Mirza's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Mirza is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Mirza to 1 more hospital and 2 medical groups, each named with a free account. Dr. Mirza's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirza practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mirza's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mirza is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Mirza is licensed in California.

CMS data shows 629 Medicare services from Dr. Mirza across 8 procedure codes in 2024, for 317 Medicare patients. Medicare paid $46,474 for them.

CMS counts 317 Medicare patients who saw Dr. Mirza in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 25% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirza's median patient age at 61, with 54% women.

In 2024, Dr. Mirza wrote 318 Medicare Part D claims for 75 patients. 38% of them were for generic drugs. CMS names the drug for 176 of them, across 6 drugs with 11 or more claims each, at $83,809 in total drug cost. In 2023, CMS named 255 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mirza for performance year 2024, reported as part of a group. Dr. Mirza accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirza as offering telehealth.

Dmand AI links 7 papers to Dr. Mirza, published from 2018 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Cystic Fibrosis and Lung. Dr. Mirza has published most often in J Cyst Fibros. Dr. Mirza's most frequent co-authors are Paul K. Mohabir, MD, Andrea Michelle Jonas, MD and Laveena Chhatwani, MD.

CMS Open Payments shows 1 general payment to Dr. Mirza from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Vertex Pharmaceuticals Incorporated paid the most, $125.

Dr. Mirza graduated from Loyola University Chicago Stritch School of Medicine in 2013. Dr. Mirza is a member of ATS.

Dr. Mirza is in network with 6 carriers, including Aetna, HCSC and United Healthcare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.